Skip to content

News archive

 Elin Tveito Lidman, CEO of Orkla Alternative Proteins (OAP)

Orkla wants to be one of the foremost players in alternative proteins in Europe

Orkla’s goal is to become one of Europe’s leading competitors in the alternative proteins space before 2030. That is why the Group is now establishing Orkla Alternative Proteins (OAP) as a separate business unit.
“We are just at the beginning of a massive shift towards alternative protein sources. For Orkla, alternative proteins is an important priority area that offers major growth opportunit

Show more

Welcome to Orkla Global!

Orkla ASA is a leading industrial investment company. Its scope of activity is brands and consumer-oriented companies. At present, Orkla has 11 portfolio companies.

Orkla has a long-term, industrial approach to its portfolio companies. We invest in companies where we can contribute to further value creation through our industry expertise, consumer insight and experience in building leading brands.

Orkla ASA is listed on the Oslo Stock Exchange.

Orkla Global

Visit our other newsrooms